New partnership to supply human insulin to millions of people across the African continent Novo Nordisk halts once- weekly injectable semaglutide kidney outcomes trial based on positive interim analysis Novo Nordisk and UNICEF extend joint initiative to prevent global childhood obesity 3/2023 • SHARE Magazine 3
Download PDF file